Free shipping on all orders over $ 500


Cat. No. M10298
AZD5305 Structure


Size Price Availability Quantity
5mg USD 300  USD300 In stock
10mg USD 460  USD460 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
Biological Activity

AZD5305 is a potent and oral active, second-generation PARP (highly selective PARP1) inhibitor. AZD5305 showed highly effective and sustained anti-tumor activity in selected BRCAm xenograft and PDX in vivo models. At the same time, AZD5305 also showed benefits when used in combination with chemotherapy.

Customer Product Validations & Biological Datas
Source AZD5305
Method orally
Cell Lines BRCAm xenograft and PDX models
Concentrations 0.01~1mg/kg
Incubation Time -
Results AZD5305 shows benefit in combination with chemotherapy.
Source AZD5305
Method orally (PO)
Cell Lines BRCAm xenograft and PDX models
Concentrations 0.01~10mg/kg
Incubation Time 20, 31, 35 days
Results AZD5305 demonstrates high and sustained anti-tumour activity in a selection of BRCAm xenograft and PDX models in vivo.
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Chemical Information
Molecular Weight 406.48
Formula C22H26N6O2
CAS Number 2589531-76-8
Purity 99.60%
Storage at -20°C

[1] Anna D. Staniszewska, et al. AACR. The novel PARP1-selective inhibitor, AZD5305, is efficacious as monotherapy and in combination with standard of care chemotherapy in the in vivo preclinical models

Related PARP Products
Fluzoparib (SHR3162)

Fuzuopali is a poly (ADP-ribose) polymerase inhibitor (PARP) inhibitor with IC50 of 1.46±0.72 nM for a cell‐free enzymatic assay, with superior antitumor activity.


BRCA1-IN-2 is a cell-permeable protein-protein interaction (PPI) inhibitor for BRCA1, with IC50 of 0.31 μM and Kd of 0.3 μM.


RBN-2397 is a potent and orally active NAD+ competitive inhibitor of PARP7 (IC50<3 nM).


Pamiparib (BGB-290) is an orally active, potent, highly selective inhibitor of PARP1 and PARP2 with IC50 values of 0.9 nM and 0.5 nM, respectively.

BGP-15 2HCl

BGP-15 is a novel poly(ADP-ribose) polymerase inhibitor with an IC50 and a Ki of 120 μM and 57 μM, respectively.

Abmole Inhibitor Catalog 2017

Keywords: AZD5305, AZD-5305 supplier, PARP, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.